Crescent Biopharma, Inc. - Common Stock — Cash Flow (NASDAQ:CBIO)

Financials

Cash from operating activities -39.24 M-57.49 M-46.46 M-34.88 M-31.1 M-71.53 M -72.68 M Cash from investing activities -68.51 K-14.94 K-84.19 K-21.39 K20.03 K-72.92 M -79.17 M Cash from financing activities 18.14 M10.72 M4.16 M28.82 M5 398322.98 M 170.8 M Free cash flow -39.24 M-57.49 M-46.46 M-34.88 M-31.1 M-144.45 M -81.62 M